Navigation Links
Ivera Medical Corporation Denies Patent Infringement Allegations
Date:6/7/2012

SAN DIEGO, June 7, 2012 /PRNewswire/ -- Ivera Medical Corporation, a company that manufactures, markets, and sells the Curos® Disinfecting Port Protector, a device that disinfects and protects the entry port on needleless valves used with intravenous lines, categorically denies all claims made by Catheter Connections in their recent legal filings against Ivera. Each Catheter Connections claim against Ivera is without merit.

In August 2010, Ivera was issued U.S. Patent No. 7,780,794, and on July 26, 2011 it was issued U.S. Patent No. 7,985,302. Despite these patents, companies have chosen to continue the manufacture and sale of their infringing disinfection caps. In response, Ivera has filed suits in federal district court in San Diego alleging patent infringement by market players including Excelsior Medical, Hospira Worldwide, and Catheter Connections.

In an effort to invalidate the Ivera patents, a competitor requested that the United States Patent and Trademark Office (USPTO) re-exam the patents '794 and '302. In May, 2012, the USPTO completed the detailed reexamination and reaffirmed the validity of Ivera's patents, which cover key aspects of products used to disinfect intravenous access ports. Ivera respects the rights granted by the USPTO and will vigorously defend those rights.

"Ivera was the first to pioneer the disinfection cap market and we are a leading provider of this technology," according to Bob Rogers, CEO of Ivera Medical. "Once again, we will vigorously defend our intellectual property and our rights to bring new and better disinfection solutions to market."

About Ivera Medical

Ivera Medical Corporation is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at http://www.curos.com.

Contact:
Bob Rogers
Chief Executive Officer
Ivera Medical Corp.
760-612-6090


'/>"/>
SOURCE Ivera Medical Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider ... and other difficult to transfect cells, announces its launch of the PluriQ™ G9™ ... Editing System is a complete system for culturing and transfecting human pluripotent ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Finally, a bruise ... venous procedures, dermaka cream can be incorporated into the post-surgical treatment plans of a ... procedures. , dermaka cream is very effective for bruising and causes a rapid ...
(Date:6/24/2016)... ... 24, 2016 , ... Southern Illinois University School of Dental ... Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy (MOM). They will host ... Collinsville. , They expect to treat approximately 2,000 patients from Illinois, ...
(Date:6/24/2016)... ... June 24, 2016 , ... SpiritQuest Sedona Retreats, located in Arizona ... surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, and Boynton Canyon. The new ... Lodge at Sedona as well as the Sedona Rouge, both popular accommodations for SpiritQuest ...
Breaking Medicine News(10 mins):